NCT05132205View on ClinicalTrials.gov

Radiofrequency Ablation of Papillary Thyroid Microcarcinoma

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2024

Conditions
Papillary Thyroid Cancer
Interventions
PROCEDURE

Radiofrequency Ablation

Radiofrequency Ablation using RFMedical device.

Trial Locations (1)

21278

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

RF Medical Co., Ltd

UNKNOWN

lead

Johns Hopkins University

OTHER

NCT05132205 - Radiofrequency Ablation of Papillary Thyroid Microcarcinoma | Biotech Hunter | Biotech Hunter